`To:
`Cc:
`
`Subject:
`Date:
`
`Fishman, Deborah
`Trials; Rea, Terry (External)
`paul@rmmslegal.com; wrakoczy@rmmslegal.com; hsalmen@rmmslegal.com; nmclaughlin@rmmslegal.com;
`MYL_REG_IPR@rmmslegal.com; Caine, David A.; Ho, Alice; Reines, Victoria; Cobb, Jeremy; Reisner, Daniel; Wilk,
`Matthew M.; Regeneron Eylea IPRs; Green, Lora (External); ychu@wsgr.com; rcerwinski@geminilaw.com;
`azalcenstein@geminilaw.com; bmorris@geminilaw.com; Yellin, Deborah; Lentz, Shannon
`RE: Motions for Joinder to IPR2021-00880 and IPR2021-00881
`Monday, December 20, 2021 6:30:35 PM
`
`CAUTION: This email has originated from a source outside of USPTO. PLEASE CONSIDER THE SOURCE before
`responding, clicking on links, or opening attachments.
`
`Dear Ms. King,
`
`I am counsel of record for Patent Owner, Regeneron, in these proceedings and write to advise the
`Panel that, based on the contents of the Petitions in IPR2022-00298, IPR2022-00301, IPR2022-
`00257, IPR2022-00258, and the representations of Petitioners Apotex and Celltrion in their
`respective motions for joinder, Patent Owner agrees to waive its POPR in those IPRs.
`
`Please let us know if the Panel has any questions or requires any clarification.
`
`With best regards,
`Deborah
`
`From: Trials <Trials@USPTO.GOV>
`Sent: Wednesday, December 15, 2021 11:16 AM
`To: Fishman, Deborah <Deborah.Fishman@arnoldporter.com>; Rea, Terry (External)
`<TRea@crowell.com>; Trials <Trials@USPTO.GOV>
`Cc: paul@rmmslegal.com; wrakoczy@rmmslegal.com; hsalmen@rmmslegal.com;
`nmclaughlin@rmmslegal.com; MYL_REG_IPR@rmmslegal.com; Caine, David A.
`<David.Caine@arnoldporter.com>; Ho, Alice <Alice.Ho@arnoldporter.com>; Reines, Victoria
`<Victoria.Reines@arnoldporter.com>; Cobb, Jeremy <Jeremy.Cobb@arnoldporter.com>; Reisner,
`Daniel <Daniel.Reisner@arnoldporter.com>; Wilk, Matthew M. <Matthew.Wilk@arnoldporter.com>;
`Regeneron Eylea IPRs <RegeneronEyleaIPRs@arnoldporter.com>; Green, Lora (External)
`<lgreen@wsgr.com>; ychu@wsgr.com; rcerwinski@geminilaw.com; azalcenstein@geminilaw.com;
`bmorris@geminilaw.com; Yellin, Deborah <DYellin@crowell.com>; Lentz, Shannon
`<SLentz@crowell.com>
`Subject: RE: Motions for Joinder to IPR2021-00880 and IPR2021-00881
`
` External E-mail
`
`Counsel: A conference call has been scheduled for Friday, @ 2:00 PM ET. The dial-in information is
`below:
`
`XXXXXXXXX
`
`XXXXXXXXXX
`
`
`
`
`Thank you,
`
`Maria King
`Deputy Chief Clerk for Trials
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`703-756-1288
`
`
`
`From: Fishman, Deborah <Deborah.Fishman@arnoldporter.com>
`Sent: Wednesday, December 15, 2021 2:08 PM
`To: Rea, Terry (External) <TRea@crowell.com>; Trials <Trials@USPTO.GOV>
`Cc: paul@rmmslegal.com; wrakoczy@rmmslegal.com; hsalmen@rmmslegal.com;
`nmclaughlin@rmmslegal.com; MYL_REG_IPR@rmmslegal.com; Caine, David A.
`<David.Caine@arnoldporter.com>; Ho, Alice <Alice.Ho@arnoldporter.com>; Reines, Victoria
`<Victoria.Reines@arnoldporter.com>; Cobb, Jeremy <Jeremy.Cobb@arnoldporter.com>; Reisner,
`Daniel <Daniel.Reisner@arnoldporter.com>; Wilk, Matthew M. <Matthew.Wilk@arnoldporter.com>;
`Regeneron Eylea IPRs <RegeneronEyleaIPRs@arnoldporter.com>; Green, Lora (External)
`<lgreen@wsgr.com>; ychu@wsgr.com; rcerwinski@geminilaw.com; azalcenstein@geminilaw.com;
`bmorris@geminilaw.com; Yellin, Deborah <DYellin@crowell.com>; Lentz, Shannon
`<SLentz@crowell.com>
`Subject: RE: Motions for Joinder to IPR2021-00880 and IPR2021-00881
`
`CAUTION: This email has originated from a source outside of USPTO. PLEASE CONSIDER THE SOURCE before
`responding, clicking on links, or opening attachments.
`
`Dear Ms. King,
`
`Petitioner and Patent Owner have conferred, and we are both available at 2 pm ET on Friday,
`December 17th.
`
`With best regards,
`Deborah
`
`From: Rea, Terry <TRea@crowell.com>
`Sent: Wednesday, December 15, 2021 7:15 AM
`To: Trials <Trials@USPTO.GOV>
`Cc: paul@rmmslegal.com; wrakoczy@rmmslegal.com; hsalmen@rmmslegal.com;
`nmclaughlin@rmmslegal.com; MYL_REG_IPR@rmmslegal.com; Fishman, Deborah
`<Deborah.Fishman@arnoldporter.com>; Caine, David A. <David.Caine@arnoldporter.com>; Ho,
`Alice <Alice.Ho@arnoldporter.com>; Reines, Victoria <Victoria.Reines@arnoldporter.com>; Cobb,
`Jeremy <Jeremy.Cobb@arnoldporter.com>; Reisner, Daniel <Daniel.Reisner@arnoldporter.com>;
`Wilk, Matthew M. <Matthew.Wilk@arnoldporter.com>; Regeneron Eylea IPRs
`
`
`
`<RegeneronEyleaIPRs@arnoldporter.com>; Green, Lora (External) <lgreen@wsgr.com>;
`ychu@wsgr.com; rcerwinski@geminilaw.com; azalcenstein@geminilaw.com;
`bmorris@geminilaw.com; Yellin, Deborah <DYellin@crowell.com>; Lentz, Shannon
`<SLentz@crowell.com>
`Subject: RE: Motions for Joinder to IPR2021-00880 and IPR2021-00881
`
` External E-mail
`
`Dear Ms. King,
`
`Counsel for Apotex is available at the proposed time of 2 pm ET on Friday, December 17th.
`
`Please note that we corrected the typographical error in Dr. McLaughlin’s email address in this reply
`email.
`
`Regards,
`
`Terry
`
`Teresa Stanek Rea
`TRea@crowell.com
`Direct: 1.202.624.2620 | Fax: 1.202.628.5116
`
`Crowell & Moring LLP | www.crowell.com
`1001 Pennsylvania Avenue NW
`Washington, DC 20004
`
`From: Trials <Trials@USPTO.GOV>
`Sent: Wednesday, December 15, 2021 9:48 AM
`To: Rea, Terry <TRea@crowell.com>; Trials <Trials@USPTO.GOV>
`Cc: paul@rmmslegal.com; wrakoczy@rmmslegal.com; hsalmen@rmmslegal.com;
`'nmclaughlin@rmmslegal.com; MYL_REG_IPR@rmmslegal.com;
`Deborah.Fishman@arnoldporter.com; David.Caine@arnoldporter.com; Alice.Ho@arnoldporter.com;
`Victoria.Reines@arnoldporter.com; Jeremy.Cobb@arnoldporter.com;
`Daniel.Reisner@arnoldporter.com; Matthew.Wilk@arnoldporter.com;
`RegeneronEyleaIPRs@arnoldporter.com; Green, Lora (External) <lgreen@wsgr.com>;
`ychu@wsgr.com; rcerwinski@geminilaw.com; azalcenstein@geminilaw.com;
`bmorris@geminilaw.com; Yellin, Deborah <DYellin@crowell.com>; Lentz, Shannon
`<SLentz@crowell.com>
`Subject: RE: Motions for Joinder to IPR2021-00880 and IPR2021-00881
`
` External Email
`
`Counsel: The panel is available for a conference on Friday at 2 pm EST. They are also available at
`the proposed time on the 21st, should that date and time fall through. Please confirm your
`
`
`
`availability.
`
`Thank you,
`
`Maria King
`Deputy Chief Clerk for Trials
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`703-756-1288
`
`
`
`From: Rea, Terry <TRea@crowell.com>
`Sent: Wednesday, December 15, 2021 8:10 AM
`To: Trials <Trials@USPTO.GOV>
`Cc: paul@rmmslegal.com; wrakoczy@rmmslegal.com; hsalmen@rmmslegal.com;
`'nmclaughlin@rmmslegal.com; MYL_REG_IPR@rmmslegal.com;
`Deborah.Fishman@arnoldporter.com; David.Caine@arnoldporter.com; Alice.Ho@arnoldporter.com;
`Victoria.Reines@arnoldporter.com; Jeremy.Cobb@arnoldporter.com;
`Daniel.Reisner@arnoldporter.com; Matthew.Wilk@arnoldporter.com;
`RegeneronEyleaIPRs@arnoldporter.com; Green, Lora (External) <lgreen@wsgr.com>;
`ychu@wsgr.com; rcerwinski@geminilaw.com; azalcenstein@geminilaw.com;
`bmorris@geminilaw.com; Yellin, Deborah <DYellin@crowell.com>; Lentz, Shannon
`<SLentz@crowell.com>
`Subject: Motions for Joinder to IPR2021-00880 and IPR2021-00881
`
`CAUTION: This email has originated from a source outside of USPTO. PLEASE CONSIDER THE SOURCE before
`responding, clicking on links, or opening attachments.
`
`Dear Board,
`
` I
`
` am counsel for Petitioner Apotex, Inc. for recently filed IPR proceedings, IPR2022-00298, and
`IPR2022-00301. In those IPRs, we filed Motions for joinder to Mylan v. Regeneron, IPR2021-00880
`and IPR2021-00881 (“the Mylan IPRs”) on December 9, 2021.
`
` I
`
` am writing pursuant to the requirements in the Trial Practice Guide to arrange a conference call
`with the panel, petitioner, and patent owner of the first proceeding within five business days of filing
`the motion so that the panel can timely manage the proceedings.
`
`On this email, we have copied counsel for Celltrion as they also filed IPR Petitions and Motions for
`Joinder to the same Mylan IPRs.
`
`Apotex notes that Mylan does not oppose joinder of either Apotex or Celltrion in either proceeding.
`
`Counsel for all such parties can be available for a phone call during the following windows (all times
`
`
`
`in ET):
`
`December 17th from 11:00-1:00 PM and 2-3:00 PM;
`December 21st from 4-5:00 PM.
`
`
`If there is another time the Board prefers, Petitioner will work with the other parties to
`accommodate the Board’s schedule.
`
`Regards,
`
`Terry
`
`Teresa Stanek Rea
`TRea@crowell.com
`Direct: 1.202.624.2620 | Fax: 1.202.628.5116
`
`Crowell & Moring LLP | www.crowell.com
`1001 Pennsylvania Avenue NW
`Washington, DC 20004
`
`
`
`
`
`
`
`
`This communication may contain information that is legally privileged, confidential or exempt from disclosure. If you are not the intended
`recipient, please note that any dissemination, distribution, or copying of this communication is strictly prohibited. Anyone who receives
`this message in error should notify the sender immediately by telephone or by return e-mail and delete it from his or her computer.
`___________________________________________
`For more information about Arnold & Porter, click here:
`http://www.arnoldporter.com
`
`This communication may contain information that is legally privileged, confidential or exempt from disclosure. If you are not the intended
`recipient, please note that any dissemination, distribution, or copying of this communication is strictly prohibited. Anyone who receives
`this message in error should notify the sender immediately by telephone or by return e-mail and delete it from his or her computer.
`___________________________________________
`For more information about Arnold & Porter, click here:
`http://www.arnoldporter.com
`
`